Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|February 11, 2000
Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trialsP Mismetti, S Laporte-Simitsidis, B Tardy, et al.
Chronobiology International|April 11, 2000
Establishing the dose-dependent daily variations of a low molecular weight heparin (Fraxiparine) through a population approach analysis in the ratD Abrial, A Blanc, M Réhailia, et al.
British Journal of Haematology|January 1, 1997
Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double-blind randomized studyB Tardy, B Tardy-Poncet, S Laporte-Simitsidis, et al.
Haemostasis|March 17, 2001
A chronopharmacodynamic study on standard heparin, a low molecular weight heparin (nadroparin) and danaproid: establishing and comparing the daily variations of these drugs in ratsD Abrial, A Blanc, M Réhailia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysisJ C Trone, E Ollier, C Chapelle, et al.
Heart (British Cardiac Society)|April 16, 2015
Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysisF Hourcade-Potelleret, S Laporte, V Lehnert, et al.
Fundamental & Clinical Pharmacology|November 18, 1998
Pharmacokinetic and pharmacodynamic variations of acenocoumarol orally administrated either once or twice daily in patients with deep venous thrombosisP Mismetti, J Reynaud, S Laporte-Simitsidis, et al.
Thrombosis and Haemostasis|August 1, 1995
Chrono-pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteersP Mismetti, J Reynaud, B Tardy-Ponce, et al.
Therapie|March 4, 2003
[Prevention of thrombosis during pregnancy: from recommendations to practice from 26 cases]M Epinat, A Buchmüller-Cordier, D Delsart, et al.
Journal of Thrombosis and Haemostasis : JTH|January 15, 2011
Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patientsS Laporte, J Liotier, L Bertoletti, et al.
Pageof 14